Research / KSCP / Fundamental state Inspectable configuration
State dimensions Filing 0001410578-23-001838 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
15.32% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.51% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-132.81% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
241.94% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
74.96% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
0.25% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-166.85% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
41.59% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
20.52% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/5 normalized Level 3 Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/6 normalized Level 3 Jun 30, 2022 0/6 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 4/9 normalized Level 3 Dec 31, 2023 6/9 normalized Level 3 Mar 31, 2024 5/7 normalized Level 3 Jun 30, 2024 5/7 normalized Level 3 Sep 30, 2024 7/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 171.83%
Current 15.32%
Delta -156.51% Capex Intensity Decreased
Previous 15.15%
Current 0.51%
Delta -14.65% Cash Generation Increased
Previous -223.78%
Current -132.81%
Delta 90.97% Growth Increased
Previous 206.89%
Current 241.94%
Delta 35.05% Inventory Pressure Decreased
Previous 93.13%
Current 74.96%
Delta -18.17% Margin Increased
Previous -7.35%
Current 0.25%
Delta 7.60% Profitability Increased
Previous -225.09%
Current -166.85%
Delta 58.24% R And D Intensity Decreased
Previous 48.22%
Current 41.59%
Delta -6.63% Sbc Intensity Increased
Previous 15.40%
Current 20.52%
Delta 5.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.